{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:12:38Z","timestamp":1769069558845,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Public Health and Clinical Medicine, Ume\u00e5 University and the Department of Research and Development, County Council of Vasternorrland","award":["LVNFOU216571"],"award-info":[{"award-number":["LVNFOU216571"]}]},{"DOI":"10.13039\/501100009738","name":"Anna and Edwin Bergers Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.thromres.2014.02.031","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T00:00:43Z","timestamp":1393977643000},"page":"795-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Mechanical heart valve prosthesis and warfarin \u2013 Treatment quality and prognosis"],"prefix":"10.1016","volume":"133","author":[{"given":"Bartosz","family":"Grzymala-Lubanski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashkan","family":"Labaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erling","family":"Englund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Sj\u00e4lander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.thromres.2014.02.031_bb0010","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1001\/jama.2012.54506","article-title":"Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding","volume":"308","author":"M\u00e9rie","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2014.02.031_bb0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical valve prosteses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2014.02.031_bb0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mtc.2002.121162","article-title":"Better anticoagulation control improves survival after valve replacement","volume":"123","author":"Butchart","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thromres.2014.02.031_bb0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review","volume":"1","author":"Wan","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.thromres.2014.02.031_bb0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2005.01605.x","article-title":"Gains and losses of warfarin therapy as performed in an anticoagulation clinic","volume":"259","author":"Njaastad","year":"2006","journal-title":"J Int Med"},{"issue":"4","key":"10.1016\/j.thromres.2014.02.031_bb0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.thromres.2014.02.031_bb0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2014.02.031_bb0060","series-title":"Fundamentals of biostatistics","author":"Rosner","year":"2010"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2014.02.031_bb0065","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0049-3848(13)70010-0","article-title":"Anticoagulant choices in pregnant women with mechanical heart valves: balancing maternal and fetal risks \u2013 the difference the dose makes","volume":"131","author":"McLintock","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2014.02.031_bb0070","doi-asserted-by":"crossref","first-page":"445S","DOI":"10.1378\/chest.102.4_Supplement.445S","article-title":"Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves","volume":"102","author":"Dalen","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2014.02.031_bb0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJM199608083350607","article-title":"Prosthetic heart valves","volume":"335","author":"Vongpatanasin","year":"1996","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.thromres.2014.02.031_bb0080","first-page":"445","article-title":"Fifteen years\u2019 single-center experience with the ATS bileaflet valve","volume":"18","author":"Van Nooten","year":"2009","journal-title":"J Heart Valve Dis"},{"issue":"6","key":"10.1016\/j.thromres.2014.02.031_bb0140","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1067\/mtc.2001.113754","article-title":"Twenty years\u2019 experience with the Medtronic Hall valve","volume":"121","author":"Butchart","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thromres.2014.02.031_bb0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.bioeng.6.040803.140111","article-title":"Fluid mechanics of heart valves","volume":"6","author":"Yoganathan","year":"2004","journal-title":"Annu Rev Biomed Eng"},{"issue":"15","key":"10.1016\/j.thromres.2014.02.031_bb0110","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1161\/CIRCULATIONAHA.108.190748","volume":"118","author":"Bonow","year":"2008","journal-title":"Circulation"},{"issue":"2 Suppl.","key":"10.1016\/j.thromres.2014.02.031_bb0115","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1378\/chest.11-2286","article-title":"Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence \u2013 Based Clinical Practice Guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.thromres.2014.02.031_bb0120","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2014.02.031_bb0125","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.750000","volume":"118","author":"Connolly","year":"2008","journal-title":"Circulation"},{"issue":"9745","key":"10.1016\/j.thromres.2014.02.031_bb0130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(10)61194-4","article-title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","volume":"376","author":"Wallentin","year":"2010","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.thromres.2014.02.031_bb0135","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814001108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384814001108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T20:35:53Z","timestamp":1589229353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384814001108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0049384814001108"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2014.02.031","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanical heart valve prosthesis and warfarin \u2013 Treatment quality and prognosis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2014.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}